cbdMD Expands Product Offering and National Presence with Leading Retail Partner GNC


The Company announces an expansion of product offerings online and at more than 840 GNC Holdings, LLC (GNC) retail stores nationwide.

CHARLOTTE, North Carolina, March 3, 2022 /PRNewswire-PRWeb/ — cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”), one of the world’s largest and most recognized health and wellness CBD companies , announced an expansion of its product offerings online and at more than 840 GNC Holdings, LLC (GNC) retail stores nationwide.

cbdMD first partnered with GNC in August 2020, and included rolling out three themed SKUs to less than 100 retail stores nationwide. Due to consumer receptivity and overall shopping performance, cbdMD is adding 11 additional SKUs, available online and in over 840 retail stores nationwide. Expanding product offerings include a variety of ingestible products: functional CBD gummies, sleeping pills, capsules and tinctures. Topicals will continue to be available for purchase online and in-store. Along with product and store expansion, cbdMD is gaining a more visible footprint in online and retail stores, positioning the products alongside other everyday health and wellness options for consumers.

“It is exciting to expand our partnership with GNC to better provide a full suite of product offerings to consumers for everyday wellness choices. We are proud to offer GNC customers a variety of products Top-notch CBD and wellness products, all designed to complement their daily routine. We believe this is just the next step in raising awareness and increasing the accessibility of CBD products to millions of people across the country,” said Pancho Mangual executive vice president of sales for cbdMD, Inc.

For more information about cbdMD, Inc. at GNC, go here.

About CBDMD, Inc.
cbdMD, Inc. is one of the most trusted and trusted cannabidiol (CBD) brands, with a full line of THC1-free CBD products made in the USA. The cbdMD brand currently includes over 130 SKUs of premium CBD products, including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleeping pills , CBD drink mixes, and full-spectrum CBD options. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products, including tinctures, chews and topicals in varying strengths, and our cbdMD Botanicals brand of beauty and skincare includes 15 SKUs, including face oil and serum, toner, moisturizers, face masks, exfoliators, and body care. To learn more about cbdMD and its full line of USA-grown, THC1-free CBD oil and full-spectrum products, please visit http://www.cbdmd.comfollow cbdMD on Instagram and Facebook or visit one of the 6,000 outlets that sell cbdMD products.

Forward-looking statements
This press release contains certain forward-looking statements that are based on current expectations and involve certain risks and uncertainties within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of words such as ‘ ‘should,’ ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”plans,” ”plans,” ”expects”, ”plans” and ”proposes”. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. and could cause actual results to differ materially from those expressed or anticipated in forward-looking statements, including, without limitation, statements made regarding the expansion of the consumer market for CBD products, our ability to increase our market share, the availability of the Amazon platform for our CBD products, our ability to grow our business and significantly increase our revenue, our ability to effectively leverage our partnerships and brand sponsorships, our ability to be competitive in our market, our ability to achieve our net sales forecasts and our ability to report profitable operations in the future. You are urged to carefully review and consider all cautionary and other information, including statements made under “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the financial year closed September 30, 2021 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, many of which are generally beyond the control of cbdMD, Inc. and are difficult to predict. CBDMD, Inc. assumes no obligation to update forward-looking statements except as required by law. Information that appears on our websites and social media platforms, including but not limited to Instagram and Facebook, is not part of this press release.
1 THC Free is defined as below the level of detection using validated scientific methods.

Robert Pettway Director of Paid Media
(423) 503-5225

John Weston
Investor Relations Director
(704) 249-9515

Media Contact

John WestoncbdMD, 704-445-3064, john.weston@cbdmd.com



Comments are closed.